Piperidine compounds useful as PPAR activators

Details Piperidine compounds useful as PPAR activators Piperidine compounds useful as PPAR activators

2007-04-03

2007-04-03

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S184000, C514S330000

Reexamination Certificate

active

10720942

ABSTRACT:
PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.

REFERENCES:
patent: 3801581 (1974-04-01), Rossi et al.
patent: 4460594 (1984-07-01), Markwell
patent: 4476311 (1984-10-01), Shetty et al.
patent: 4618614 (1986-10-01), Hausberg et al.
patent: 5411972 (1995-05-01), Komoto et al.
patent: 5420305 (1995-05-01), Ramig et al.
patent: 5658944 (1997-08-01), Chapman, Jr. et al.
patent: 5994356 (1999-11-01), Pieper et al.
patent: 6153758 (2000-11-01), Sannicolo et al.
patent: 6303637 (2001-10-01), Bao et al.
patent: 6323229 (2001-11-01), Howard
patent: 6362203 (2002-03-01), Mogi et al.
patent: 6376494 (2002-04-01), Childers et al.
patent: 0548798 (1993-06-01), None
patent: 02173426 (2002-06-01), None
patent: WO 9210468 (1992-06-01), None
patent: WO 9219594 (1992-11-01), None
patent: WO 9307141 (1993-04-01), None
patent: WO 9312086 (1993-06-01), None
patent: WO 96/02250 (1996-02-01), None
patent: WO 9602250 (1996-02-01), None
patent: WO 9736579 (1997-10-01), None
patent: WO 9805331 (1998-02-01), None
patent: WO 0014066 (2000-03-01), None
patent: WO 0023407 (2000-04-01), None
patent: WO 01/90101 (2001-11-01), None
patent: WO 0181310 (2001-11-01), None
patent: WO 0185716 (2001-11-01), None
patent: WO 0190101 (2001-11-01), None
patent: WO 0228834 (2002-04-01), None
patent: WO 0230896 (2002-04-01), None
patent: WO 02064139 (2002-08-01), None
patent: WO 02064549 (2002-08-01), None
Palani et al., Journal of Medicinal Chemistry, 2005, 48, 4746.
Heinone, T. Currect Atherosclerosis Reports, 2002, 4(1), Summary.
Thomas et al., Archives des Maladies du Coeur et des Vaisseaux, 1992, 85, Summary.
Narayanaswamy et al., J. Vas. Intervent. Radiol., 11(1), 2000, Summary.□□
Archives des Maladies du Coeur et des Vaisseaux, 1991, 84/11, Summary.
Human and Ecological Risk Assessment, 1999, 84/11, Summary.
Patani et al., Chem. Rev., 1996, 96,3147-3176.
Komoto, T., et al., New Strong Fibrates with Piperidne Moiety,Chem. Pharm. Bull., vol. 48, No. 12, pp. 1878-1985 (2000).

Affiliated with

Also associated with

Rating

Piperidine compounds useful as PPAR activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine compounds useful as PPAR activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine compounds useful as PPAR activators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3780089